BackGlobus Medical Overview

Globus Medical Receivables

Track Globus Medical's receivables ($690M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$686.43M
↑ 27.56% YoYΔ $148.32M vs prior year quarter

Peer average

Loading

Globus Medical Receivables History

Loading

Globus Medical vs. peers: Receivables Comparison

Loading

Globus Medical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Globus Medical (GMED) FAQ

Globus Medical (GMED) currently reports a receivables of $690M as of March 2026. That compares with $540M in the prior-year period — up 27.6% year over year. Use the charts on this page to explore Globus Medical's receivables history and peer comparisons.

Globus Medical's receivables increased from $540M to $690M — a 27.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Globus Medical reported $690M in receivables as of March 2026. That compares with $540M in the prior-year period — up 27.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $690M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Globus Medical, and consider following GMED for alerts when major investors trade the stock.

Globus Medical is classified in the Healthcare sector. On receivables, it currently shows $690M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GMED with unrelated industries.